Clinical Trial Update: Forxiga Tablets Specific Clinical Experience Investigation for Elderly

View source ↗

Summary

This clinical trial update reports the completion of a study evaluating Forxiga (dapagliflozin) tablets in elderly patients with Type 2 Diabetes Mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Forxiga (dapagliflozin)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Status: COMPLETED